Strategic Initiative

Slingshot members are tracking this corporate initiative:

PharmaMar (PHM.MC) Enters Exclusive License Agreement in Japan with Chugai Pharma (CHGCY) for Marine-Derived Cancer Candidate PM1183

Source Link:
https://www.pharmamar.com/2016/12/22/pharmamar-y-chugai-pharmaceutical-firman-un-acuerdo-de-licencia-y-comercializacion-para-pm1183-en-japon/

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CHGCY
100%
PHM.MC
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Dec 22, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Japan, Marine-derived, Cancer Candidate, Pm1183, Lurbinectedin
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.